Lexicon Pharmaceuticals Financial Overview
Lexicon Pharmaceuticals's market cap is currently $417.91M. The company's EPS TTM is $-0.04; its P/E ratio is -6.23; Lexicon Pharmaceuticals is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
